harvard pilgrim glp-1 coverage Lilly's Trulicity joins pay-for-performance trend with deal Tufts Health Plan, Harvard Pilgrim

3ac) and males (Fig

With the explosion in popularity of injectable GLP-1s, pharmaceutical companies are now in a heated race to develop weight-loss pills that are just as effective

Complementing randomized trial evidence, extensive real-world observational data from large healthcare databases consistently demonstrate associations between GLP-1 receptor agonist utilization and decreased risks of MALOs involving cirrhosis, hepatic decompensation, HCC, and death from hepatic causes in patients with MASLD and type 2 diabetes

doi:10.2196/24174 Clinical study finds that offering digital health platform Cardihab increases participation in cardiac rehabilitation - Digital Health Science News - summary Evidence Presentations And Resources Canadian Cardiovascular Congress Presented at the Canadian Cardiovascular Congress 2022 Rivers JT, Smith C, Smith I, Cameron J

Stickel F, Kessebohm K, Weimann R, Seitz HK

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al